Early protein expression profile in bronchoalveolar lavage fluid and clinical outcomes in primary graft dysfunction after lung transplantation
Open Access
- 8 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 58 (2), 379-388
- https://doi.org/10.1093/ejcts/ezaa043
Abstract
Primary graft dysfunction (PGD) remains a major post-transplant complication and is associated with increased morbidity and mortality. Mechanisms evoking PGD are not completely clear, but inflammation plays a central role. We investigated the association between PGD and inflammatory proteins present in immediate postoperative bronchoalveolar lavage. All double-lung recipients transplanted at our institution from 2002 to 2018 were included in our study. We retrospectively selected 80 consecutive lung transplant recipients with different PGD grades (n = 20 for each PGD grades 0–1 to 2–3). In bronchoalveolar lavage performed within the first 24 h after donor aortic cross-clamping following lung transplantation, concentrations of 30 cytokines, chemokines and growth factors were assessed by enzyme-linked immunosorbent assay (ELISA) and correlated with donor and recipient demographics and outcomes. For analysis, 2 groups were defined: ‘mild’ PGD (grade 0–1) and ‘severe’ PGD (grades 2–3). Significant differences between mild and severe PGD were found in 8 biomarkers [interleukin (IL)-6, IL-10, IL-13, eotaxin, granulocyte colony-stimulating factor, interferon γ, macrophage inflammatory protein 1α, surfactant protein D (SP-D); P < 0.05]. Increased IL-10 and IL-13, but none of the other proteins, were associated with short-term outcome (longer time to extubation; P = 0.005 and P < 0.0001; increased intensive care unit stay; P = 0.012 and P < 0.0001; and hospital stay; P = 0.041 and P = 0.002). There were no significant differences in donor and recipient characteristics between the groups. Expression profiles of key inflammatory mediators in bronchoalveolar lavage fluid differed significantly between lung transplant recipients with severe versus mild PGD and correlated with clinical outcome variables. Further research should focus on the early mechanisms leading to PGD.Keywords
Funding Information
- Research Fund-Flanders (FWO 12G8715N)
- KU Leuven University (C24/15/030, C16/19/005)
- UZ Leuven (STG 015/23)
- FWO
- UZ Leuven Clinical Research Fund (C24/18/073)
This publication has 23 references indexed in Scilit:
- A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantationThe Journal of Heart and Lung Transplantation, 2012
- Effect of Single vs Bilateral Lung Transplantation on Plasma Surfactant Protein D Levels in Idiopathic Pulmonary FibrosisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2011
- Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological processAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Plasma Levels of Receptor for Advanced Glycation End Products, Blood Transfusion, and Risk of Primary Graft DysfunctionAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung TransplantationAmerican Journal of Transplantation, 2009
- IL-13 Effector FunctionsAnnual Review of Immunology, 2003
- Interleukin-8 Release during Early Reperfusion Predicts Graft Function in Human Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2002
- IL-13 Activates STAT6 and Inhibits Liver Injury Induced by Ischemia/ReperfusionThe American Journal of Pathology, 1999
- Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC: A comparison between IL-4 and IL-13Cytokine, 1995
- THE PARTICIPATION OF TUMOR NECROSIS FACTOR IN THE PATHOGENESIS OF LUNG ALLOGRAFT REJECTION IN THE RATTransplantation, 1993